AbbVie’s Rinvoq scores its 7th FDA nod, this one for Crohn’s disease kdunleavy Thu, 05/18/2023 – 15:54 More: AbbVie's Rinvoq scores its 7th FDA nod, this one for Crohn's disease Source: fierce
read moreSCOTUS hands win to Sanofi, Regeneron in long-running PCSK9 feud with Amgen fkansteiner Thu, 05/18/2023 – 15:17 More: SCOTUS hands win to Sanofi, Regeneron in long-running PCSK9 feud with Amgen Source: fierce
read moreBavarian Nordic’s Jynneos vaccine up to 86% effective against mpox: CDC aliu Thu, 05/18/2023 – 12:50 More: Bavarian Nordic's Jynneos vaccine up to 86% effective against mpox: CDC Source: fierce
read moreAfter IRA, Minnesota’s drug affordability proposal draws PhRMA’s ire zbecker Thu, 05/18/2023 – 11:38 More: After IRA, Minnesota's drug affordability proposal draws PhRMA's ire Source: fierce
read moreTeva’s new CEO Francis lays out his ‘pivot to growth’ strategy kdunleavy Thu, 05/18/2023 – 11:24 More: Teva's new CEO Francis lays out his 'pivot to growth' strategy Source: fierce
read moreThe therapy is a brain-penetrant used in various combinations in patients with progressive glioblastoma More: Debiopharm commences pivotal glioblastoma therapy study Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals